Alyeska Investment Group’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Alyeska Investment Group’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-70,000	Closed	-$1.43M	–	523
2018 Q3	$1.43M	Sell	70,000 -57,977	-45%	-$1.19M	0.02%	324
2018 Q2	$2.05M	Buy	127,977 +4,093	+3%	+$58.4K	0.02%	351
2018 Q1	$1.77M	Buy	123,884 +23,884	+24%	+$326K	0.01%	356
2017 Q4	$1.31M	Hold	100,000	–	–	0.01%	371
2017 Q3	$1.92M	Buy	+100,000	New	+$2.16M	0.01%	366

Other funds holding NITE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Alyeska Investment Group's NITE Position: Q4 2018 in Review

Alyeska Investment Group sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2018, closing a stake of 70,000 shares — an estimated $1.43M sold.

Alyeska Investment Group first reported a position in NITE in Q3 2017 and held it in 5 quarters. The position peaked at $2.05M in Q2 2018. 29 funds tracked by Wall St. Rank hold NITE as of Q4 2018.

Alyeska Investment Group reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Alyeska Investment Group sold 70,000 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2018, an estimated $1.43M.
Alyeska Investment Group first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 5 quarters.
Alyeska Investment Group's Nightstar Therapeutics plc American Depositary Shares position peaked at $2.05M in Q2 2018.
29 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2018.

Based on Alyeska Investment Group's 13F filing for Q4 2018, filed 14 Feb 2019.